{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:48:53Z","timestamp":1776329333409,"version":"3.50.1"},"reference-count":0,"publisher":"Universidad Nacional de C\u00f3rdoba","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Fac Cien Med Univ Nac Cordoba"],"abstract":"<jats:p>Introducci\u00f3n: La enfermedad de Cushing (EC) es rara durante el embarazo y se asocia con complicaciones maternas y fetales significativas. El objetivo fue reportar el caso de una paciente con EC que logr\u00f3 embarazo y parto sin complicaciones tras el tratamiento con dosis bajas de cabergolina. M\u00e9todos: Mujer de 29 a\u00f1os con diagn\u00f3stico de EC (macroadenoma secretor de ACTH que produce desplazamiento del quiasma \u00f3ptico, infiltra el seno cavernoso derecho y engloba la arteria car\u00f3tida interna). Se somete a cirug\u00eda transesfenoidal con resecci\u00f3n tumoral incompleta. Luego de un a\u00f1o de estabilidad cl\u00ednica, reaparecen los s\u00edntomas por lo que se instaura tratamiento m\u00e9dico con cabergolina. Durante el tratamiento la paciente concibe embarazo y se suspende la medicaci\u00f3n. Resultados: En el primer trimestre, los par\u00e1metros cl\u00ednicos y bioqu\u00edmicos indican EC activa, por lo que se decide reinstaurar Cabergolina a dosis bajas durante el resto de la gestaci\u00f3n. Con el agonista dopamin\u00e9rgico se alcanza normalizar par\u00e1metros cl\u00ednicos y de laboratorio y la paciente dio a luz una ni\u00f1a sana a las 38 semanas, dentro de percentiles normales y sin complicaciones. Conclusi\u00f3n: El embarazo es un evento raro en pacientes con EC. Sin embargo, las consecuencias de la exposici\u00f3n materno-fetal al hipercortisolismo pueden ser graves. Nuestra experiencia con el uso de cabergolina a dosis bajas en una embarazada con EC, aporta datos favorables a los escasos reportes bibliogr\u00e1ficos existentes, sumando evidencia sobre el perfil de seguridad del f\u00e1rmaco en esta poblaci\u00f3n de pacientes.<\/jats:p>","DOI":"10.31053\/1853.0605.v80.n1.37056","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:12:39Z","timestamp":1680700359000},"page":"55-58","source":"Crossref","is-referenced-by-count":4,"title":["Enfermedad de Cushing en el embarazo y uso de cabergolina"],"prefix":"10.31053","volume":"80","author":[{"given":"Natacha Bel\u00e9n","family":"Murillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanza Fernanda","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Fux-Otta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Anahi","family":"Cecenarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12333","published-online":{"date-parts":[[2023,3,31]]},"container-title":["Revista de la Facultad de Ciencias M\u00e9dicas de C\u00f3rdoba"],"original-title":[],"link":[{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/37056\/40951","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/37056\/40951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T13:12:42Z","timestamp":1680700362000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/view\/37056"}},"subtitle":["resultados obst\u00e9tricos y neonatales"],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,31]]}},"URL":"https:\/\/doi.org\/10.31053\/1853.0605.v80.n1.37056","relation":{},"ISSN":["1853-0605","0014-6722"],"issn-type":[{"value":"1853-0605","type":"electronic"},{"value":"0014-6722","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}